Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

65.10EUR
11:35am EDT
Change (% chg)

€1.90 (+3.01%)
Prev Close
€63.20
Open
€63.10
Day's High
€65.30
Day's Low
€63.00
Volume
112,035
Avg. Vol
119,104
52-wk High
€82.60
52-wk Low
€59.00

Chart for

About

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial... (more)

Overall

Beta: 0.36
Market Cap(Mil.): €8,348.02
Shares Outstanding(Mil.): 118.36
Dividend: 0.33
Yield (%): 0.47

Financials

  BIOX.PA Industry Sector
P/E (TTM): 42.79 32.38 32.69
EPS (TTM): 1.65 -- --
ROI: 8.88 14.01 14.32
ROE: 12.39 16.77 16.04

Hologic loses bid to dismiss bioMerieux's HIV test patent case

Diagnostic testing company bioMerieux SA can move forward with a lawsuit alleging that HIV testing kits manufactured by rival Hologic Inc infringe two of its patents, a federal judge in Delaware has ruled.

Sep 26 2018

BRIEF-Biomerieux Q1 Sales Up 3.4 Percent 587 Million Euros

* NET DEBT AMOUNTED TO EUR 84 MILLION AT MARCH 31, 2018, VERSUS EUR 156 MILLION AT DECEMBER 31, 2017

Apr 19 2018

Earnings vs. Estimates